Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RAYMED LABS vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 RAYMED LABS   MYLAN
EQUITY SHARE DATA
    RAYMED LABS
Mar-23
MYLAN
Dec-18
RAYMED LABS/
MYLAN
5-Yr Chart
Click to enlarge
High Rs23,978-   
Low Rs12,190-   
Sales per share (Unadj.) Rs01,830.6-  
Earnings per share (Unadj.) Rs-0.449.7-  
Cash flow per share (Unadj.) Rs-0.4392.5-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs-5.41,980.4-  
Shares outstanding (eoy) m4.27514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x01.7-  
Avg P/E ratio x-4.462.0 -7.1%  
P/CF ratio (eoy) x-4.67.9 -58.0%  
Price / Book Value ratio x-0.31.6 -21.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m81,586,770 0.0%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m00-   
Avg. sales/employee Rs Th026,910.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0730.7-  
INCOME DATA
Net Sales Rs m0941,863 0.0%  
Other income Rs m00-   
Total revenues Rs m0941,863 0.0%   
Gross profit Rs m-2243,719 -0.0%  
Depreciation Rs m0176,354 0.0%   
Interest Rs m045,300 0.0%   
Profit before tax Rs m-222,065 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0-3,510 -0.0%   
Profit after tax Rs m-225,575 -0.0%  
Gross profit margin %025.9- 
Effective tax rate %0-15.9 0.0%   
Net profit margin %02.7- 
BALANCE SHEET DATA
Current assets Rs m0525,936 0.0%   
Current liabilities Rs m1383,465 0.0%   
Net working cap to sales %015.1- 
Current ratio x0.11.4 4.1%  
Inventory Days Days084- 
Debtors Days Days093- 
Net fixed assets Rs m2182,706 0.0%   
Share capital Rs m43501 8.5%   
"Free" reserves Rs m-660-   
Net worth Rs m-231,018,924 -0.0%   
Long term debt Rs m01,099,746 0.0%   
Total assets Rs m22,733,150 0.0%  
Interest coverage x01.5-  
Debt to equity ratio x01.1 -0.0%  
Sales to assets ratio x00.3 0.0%   
Return on assets %-109.52.6 -4,221.9%  
Return on equity %7.42.5 295.3%  
Return on capital %7.43.2 232.9%  
Exports to sales %00-  
Imports to sales %00-  
Net fx Rs m00-   
CASH FLOW
From Operations Rs m-2195,719 -0.0%  
From Investments Rs m2-101,165 -0.0%  
From Financial Activity Rs mNA-91,177 -0.0%  
Net Cashflow Rs m01,621 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.58 Rs / USD

Compare RAYMED LABS With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare RAYMED LABS With: DISHMAN PHARMA  ANUH PHARMA  UNICK FIX-A-FORM AND PRINTERS  BERYL DRUGS  GRANULES INDIA  



Today's Market

Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.